Onward Therapeutics
@onward-therapeutics.com
We are a clinical-stage oncology company focused on identifying innovative technologies and advancing truly breakthrough medicines for the treatment of cancer.
Onward Therapeutics's Company Logos
Onward Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#6F9DBC
Ship Cove
111, 157, 188
204, 36, 59
41, 16, 0, 26
#FCD29D
Cherokee
252, 210, 157
33, 94, 80
0, 17, 38, 1
#003276
Midnight Blue
0, 50, 118
215, 100, 23
100, 58, 0, 54
About Onward Therapeutics
Onward Therapeutics SA is a development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. With a team of experienced professionals in translational science and drug development, the company acquires licenses for potential development candidates and invests in transformative technology platforms. Located at Biopôle, a life sciences campus in Epalinges near Lausanne, Switzerland, Onward Therapeutics also operates from Paris, France, and Taipei, Taiwan.
Led by Chairman and CEO C. Grace Yeh, along with Chief Medical Officer Alain Herrera and Chief Scientific Officer A. Onward Therapeutics is committed to advancing the field of oncology by bringing innovative treatments to patients.
Through collaborations and partnerships, the company strives to make a significant impact in the fight against cancer
Company type
Privately Held
Year founded
2019
Company size
2-10 employees
